
The success of zzso zzso in clinical practice is dependent on good zzso Finding a suitable target is the most important part as other properties of the zzso can be altered by genetic zzso zzso that target zzso zzso offer less toxic zzso treatment than currently available drugs and the first zzso zzso approved for human use is an zzso agent for treating rejection of zzso zzso Human trails of zzso zzso to treat septic shock have been done and zzso are also being developed to target common pathogens such as zzso zzso zzso Although zzso zzso against cancer have been much zzso their success has been limited by the poor access to the inside of zzso Treatment of blood zzso has been more successful and a human zzso against B cell zzso is being clinically zzso As knowledge about natural immune responses and zzso engineering increases many more zzso are likely to feature in clinical zzso 

